CN104288544A - Medicament for treating chronic obstructive pulmonary disease - Google Patents
Medicament for treating chronic obstructive pulmonary disease Download PDFInfo
- Publication number
- CN104288544A CN104288544A CN201410458173.8A CN201410458173A CN104288544A CN 104288544 A CN104288544 A CN 104288544A CN 201410458173 A CN201410458173 A CN 201410458173A CN 104288544 A CN104288544 A CN 104288544A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicament
- radix scutellariae
- obstructive pulmonary
- chronic obstructive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/44—Elemental carbon, e.g. charcoal, carbon black
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
- A61K36/855—Clerodendrum, e.g. glorybower
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament for treating chronic obstructive pulmonary disease. The medicament for treating chronic obstructive pulmonary disease is prepared from the following ingredients, by weight, 14-19 parts of blackberry lily, 11-15 parts of gentrin knotweed, 9-10 parts of sappan wood, 15-18 parts of Scutellaria baicalensis, 9-13 parts of Scutellaria baicalensis, 25-30 parts of Chinese garlic, 19-23 parts of clerodendroa cyrtophyllum, 12-18 parts of myrrh, 13-17 parts of Scutellaria baicalensis, 3-8 parts of Pepperweed Seed, 10-13 parts of bamboo charcoal, 8-12 parts of Chinese honey locust, 15-20 parts of dandelion and 3-9 parts of common cnidium fruit. The invention also relates to a preparation method of a decoction of the medicament. The medicament has characteristics of good curative effect, short treatment course, thorough curative effect, no side-effect and the like. The preparation method is simple and fast, and is easy to operate. Through many years of clinical verifications, the medicament has effects of invigorating spleen, clearing lung-heat, reducing phlegm, dispersing blood stasis, keeping the lung-qi pure and descendant and calming panting, and has effects of treating and relieving various symptoms caused by chronic obstructive pulmonary disease.
Description
Technical field
The present invention relates to a kind of medicament for the treatment of chronic obstructive pulmonary disease.
Background technology
Chronic obstructive pulmonary disease due to its number of patients many, mortality rate is high, social economical burden weight, has become an important public health problem, there is no radical cure method so far.This disease occupies the 4th of the global cause of death at present, and the World Bank/World Health Organization (WHO) announces, and will occupy the 5th of world's disease financial burden to the year two thousand twenty chronic obstructive pulmonary disease.At the important chronic respiratory system diseases that China's chronic obstructive pulmonary disease is serious harm people's health equally, its case fatality rate reaches about 4,60/,100,000.It is the general designation of one group of chronic airflow obstruction disease, include the chronic bronchitis and emphysema etc. of airflow obstruction, generally believe chronic obstructive pulmonary disease at present with air flue, pulmonary parenchyma and pulmonary vascular chronic inflammatory disease for feature, increase at the different parts alveolation macrophage of lung, T lymphocyte and neutrophilic granulocyte, some patients has eosinophilia.With chronic cough, expectoration, to breathe hard or dyspnea is feature.Treatment mainly mitigation symptoms, the prevention PD of chronic obstructive pulmonary disease, alleviates or stops decline in pulmonary function, improving mobility, improve the quality of living, reducing for the purpose of case fatality rate.The Western medicine of current treatment chronic obstructive pulmonary disease mainly contains bronchodilator (comprising theophylline class, beta-2-agonists and anticholinergic agents), coordinates the anti symptom treatment such as oxygen therapy, antibiotic, hormone and assisted ventilation.But easily there is drug resistance and toxicity in antibiotics life-time service.Often select high-grade antibiotics to the patient of repeated infection, expensive, patient is difficult to bear; The side effect of hormone is then larger.Conventional mechanical ventilation easily causes volume to hinder and ventilator pneumonia, and flatulence easily occurs the shortcoming of NPPV, needs patient compliance, and the patient that is in a bad way comparatively is difficult to tolerance; And can occur face shield break or patient respiratory asynchronous with machine, even cause breathing unexpected deterioration.Increase the weight of for primary disease that interim medicine is many starts with from removing heat from the lung and dissipating phlegm, the lung heat clearing method such as to invigorate blood circulation, and set out according to determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs spirit, as expectorant heat syndrome DINGCHUAN TANG is added and subtracted; Phlegm-damp card ERCHEN TANG is added and subtracted.The current existing defects of Chinese medical discrimination, expectorant heat, phlegm-damp is not Acute Exacerbation Period most of patients, and insufficiency of the spleen lung-heat syndrome is comparatively common, but its side's correspondence and effect poor, can not promote the use.
Summary of the invention
The technical problem to be solved in the present invention is the above-mentioned defect how overcoming prior art, provides a kind of medicament for the treatment of chronic obstructive pulmonary disease.
For solving the problems of the technologies described above, the medicament of this treatment chronic obstructive pulmonary disease is formulated according to shown weight ratio scope by following component, Rhizoma Belamcandae 14 ~ 19 parts, Rhizoma Polygoni Cuspidati 11 ~ 15 parts, Lignum Sappan 9 ~ 10 parts, Radix Scutellariae 15 ~ 18 parts, Flos Farfarae 9 ~ 13 parts, Bulbus Allii Macrostemonis 25 ~ 30 parts, Folium Isatidis 19 ~ 23 parts, Myrrha 12 ~ 18 parts, Radix Scutellariae 13 ~ 17 parts, Semen Lepidii (Semen Descurainiae) 3 ~ 8 parts, bamboo charcoal 10 ~ 13 parts, 8 ~ 12 parts, Fructus Gleditsia, Herba Taraxaci 15 ~ 20 parts, Fructus Cnidii 3 ~ 9 parts.
As optimum ratio scope, described medicament is formulated according to shown weight ratio scope by following component, Rhizoma Belamcandae 15 ~ 17 parts, Rhizoma Polygoni Cuspidati 12 ~ 14 parts, Lignum Sappan 9 ~ 10 parts, Radix Scutellariae 16 ~ 18 parts, Flos Farfarae 9 ~ 11 parts, Bulbus Allii Macrostemonis 26 ~ 28 parts, Folium Isatidis 19 ~ 21 parts, Myrrha 14 ~ 16 parts, Radix Scutellariae 13 ~ 15 parts, Semen Lepidii (Semen Descurainiae) 5 ~ 7 parts, bamboo charcoal 11 ~ 13 parts, 8 ~ 10 parts, Fructus Gleditsia, Herba Taraxaci 17 ~ 19 parts, Fructus Cnidii 5 ~ 7 parts.
As concrete optimum ratio, described medicament is formulated according to shown weight ratio by following component, Rhizoma Belamcandae 19 parts, Rhizoma Polygoni Cuspidati 11 parts, Lignum Sappan 10 parts, Radix Scutellariae 15 parts, Flos Farfarae 13 parts, Bulbus Allii Macrostemonis 25 parts, Folium Isatidis 23 parts, Myrrha 12 parts, Radix Scutellariae 17 parts, Semen Lepidii (Semen Descurainiae) 3 parts, bamboo charcoal 13 parts, 8 parts, Fructus Gleditsia, Herba Taraxaci 20 parts, Fructus Cnidii 3 parts.
As concrete optimum ratio, described medicament is formulated according to shown weight ratio by following component, Rhizoma Belamcandae 14 parts, Rhizoma Polygoni Cuspidati 15 parts, Lignum Sappan 9 parts, Radix Scutellariae 18 parts, Flos Farfarae 9 parts, Bulbus Allii Macrostemonis 30 parts, Folium Isatidis 19 parts, Myrrha 18 parts, Radix Scutellariae 13 parts, Semen Lepidii (Semen Descurainiae) 8 parts, bamboo charcoal 10 parts, 12 parts, Fructus Gleditsia, Herba Taraxaci 15 parts, Fructus Cnidii 9 parts.
As optimum proportioning, described medicament is formulated according to shown weight ratio by following component, Rhizoma Belamcandae 16 parts, Rhizoma Polygoni Cuspidati 13 parts, Lignum Sappan 10 parts, Radix Scutellariae 17 parts, Flos Farfarae 10 parts, Bulbus Allii Macrostemonis 27 parts, Folium Isatidis 20 parts, Myrrha 15 parts, Radix Scutellariae 14 parts, Semen Lepidii (Semen Descurainiae) 6 parts, bamboo charcoal 12 parts, 9 parts, Fructus Gleditsia, Herba Taraxaci 18 parts, Fructus Cnidii 6 parts.
As concrete optimum ratio, described medicament is formulated according to shown weight ratio by following component, Rhizoma Belamcandae 17 parts, Rhizoma Polygoni Cuspidati 12 parts, Lignum Sappan 10 parts, Radix Scutellariae 16 parts, Flos Farfarae 11 parts, Bulbus Allii Macrostemonis 26 parts, Folium Isatidis 21 parts, Myrrha 14 parts, Radix Scutellariae 15 parts, Semen Lepidii (Semen Descurainiae) 5 parts, bamboo charcoal 13 parts, 8 parts, Fructus Gleditsia, Herba Taraxaci 19 parts, Fructus Cnidii 5 parts.
As concrete optimum ratio, described medicament is formulated according to shown weight ratio by following component, Rhizoma Belamcandae 15 parts, Rhizoma Polygoni Cuspidati 14 parts, Lignum Sappan 9 parts, Radix Scutellariae 18 parts, Flos Farfarae 9 parts, Bulbus Allii Macrostemonis 28 parts, Folium Isatidis 19 parts, Myrrha 16 parts, Radix Scutellariae 13 parts, Semen Lepidii (Semen Descurainiae) 7 parts, bamboo charcoal 11 parts, 10 parts, Fructus Gleditsia, Herba Taraxaci 17 parts, Fructus Cnidii 7 parts.
The dosage form of the medicament of this treatment chronic obstructive pulmonary disease is the preparation method of decoction, first each component is got by above-mentioned weight portion, each component is mixed, after spraying vinegar on the mixture, dry stir-fry, is exposed to the sun the medicine of fried dry after 24h, is ground into fine powder, cross 200 mesh sieves, add water in the mixed-powder sieved with the ratio by weight 1:1, stir, obtain the medicament decoction of this treatment chronic obstructive pulmonary disease.
Pharmacology analysis
Rhizoma Belamcandae: bitter in the mouth, cold in nature; Heat-clearing and toxic substances removing, expectorant sore-throat relieving, for the pent-up of pyretic toxicity phlegm-fire, laryngopharynx swelling and pain, accumulation and obstruction of sputum, cough and asthma.
Rhizoma Polygoni Cuspidati: mildly bitter flavor, cold nature; Expelling wind and removing dampness, dissipating blood stasis analgesic therapy, relieving cough and resolving phlegm.
Lignum Sappan: sweet in the mouth, salty, property is put down; Separate blood removing blood stasis with potent drugs, reducing swelling and alleviating pain.
Radix Scutellariae: bitter in the mouth, cold in nature; GUIXIN, spleen, lung, kidney channel; Disappear hot dampness, eliminating fire and detoxication.
Flos Farfarae: acrid in the mouth, micro-hardship, warm in nature; Nourishing the lung to keep the adverse QI downward, relieving cough and resolving phlegm, coughs for new chronic cough, dyspnea and cough with excessive sputum, chronic cough hemoptysis.
Bulbus Allii Macrostemonis: acrid in the mouth, hardship, warm in nature; Activating YANG and eliminating stagnation, circulation of qi promoting intestinal stasis relieving, for thoracic obstruction pain, phlegm retention cough with asthma is heavy after letting out dysentery.
Folium Isatidis: bitter in the mouth is property Great Cold, nontoxic; Return liver, spleen two warp; Heat clearing away, removing toxic substances, removing heat from blood, hemostasis, treats seasonal epidemic pathogens headache, hot greatly, aphtha.
Myrrha: bitter in the mouth, pungent, warm in nature, nontoxic; Return liver, spleen, the heart, kidney channel; Loose blood detumescence, analgesic therapy granulation promoting.
Radix Scutellariae: bitter in the mouth, cold in nature, return lung, gallbladder, spleen, large intestine, small intestine meridian; There is heat clearing and damp drying, eliminating fire and detoxication, hemostasis and the effect such as antiabortive; Clinical practice shows that Radix Scutellariae antibacterial effect is not worse than Rhizoma Coptidis, and does not develop immunity to drugs.
Semen Lepidii (Semen Descurainiae): acrid in the mouth, hardship, property Great Cold; Eliminating pathogen from the lung for relieving asthma, line water detumescence, stop up lung for sputum, dyspnea and cough with excessive sputum, fullness and distention in the chest and hypochondrium, must not put down sleeping, and ascites pleural fluid swells, dysuria, pulmonary heart disease edema.
Bamboo charcoal: bitter in the mouth, puckery, warm in nature; Blood circulation promoting and blood stasis dispelling, strengthening the spleen to promote digestion.
Fructus Gleditsia: acrid in the mouth, salty, warm in nature, poisonous; Return lung, large intestine channel; Expelling phlegm for arresting cough, logical closing of having one's ideas straightened out, parasite killing eliminating stagnation.
Herba Taraxaci: sweet in the mouth, micro-hardship, cold in nature; Return spleen, stomach, kidney three warp; Heat-clearing and toxic substances removing, eliminating carbuncle eliminating stagnation.
Fructus Cnidii: acrid in the mouth, hardship, warm in nature, slightly poisonous; Return kidney channel; Removing toxic substances, parasite killing, dampness, dispel the wind, external treatment vulval eczema, married woman's pudendal pruritus, trichomonal vaginitis, eczema scabies, cold-damp leukorrhagia, arthralgia chiefly caused by damp pathogen lumbago, impotence due to deficiency of the kidney, cold womb is infertile.
A kind of medicament for the treatment of chronic obstructive pulmonary disease of the present invention have good effect, short treating period, curative effect thoroughly, the feature such as have no side effect, its preparation method is simple and quick, efficient, is easy to operation, through clinical verification for many years, there is spleen invigorating lung heat clearing, effect that blood stasis dispelling of reducing phlegm, respectful lung are relievingd asthma, cure mainly chronic obstructive pulmonary disease acute exacerbation, cough, pant, yellow skin of coughing up phlegm, or glue in vain, large dry stool, xerostomia, distension and fullness in the abdomen, pale tongue is fat has tooth to print, yellow and thin fur, thready and rolling pulse etc. are insufficiency of the spleen lung heat type chronic obstructive pulmonary disease.
Detailed description of the invention
Embodiment 1: first get each component by Rhizoma Belamcandae 19 parts, Rhizoma Polygoni Cuspidati 11 parts, Lignum Sappan 10 parts, Radix Scutellariae 15 parts, Flos Farfarae 13 parts, Bulbus Allii Macrostemonis 25 parts, Folium Isatidis 23 parts, Myrrha 12 parts, Radix Scutellariae 17 parts, Semen Lepidii (Semen Descurainiae) 3 parts, bamboo charcoal 13 parts, 8 parts, Fructus Gleditsia, Herba Taraxaci 20 parts, Fructus Cnidii 3 parts; Each component mixed, after spraying vinegar on the mixture, dry stir-fry, is exposed to the sun the medicine of fried dry after 24h, is ground into fine powder, crosses 200 mesh sieves, adds water, stir, obtain the medicament decoction A of this treatment chronic obstructive pulmonary disease with the ratio by weight 1:1 in the mixed-powder sieved.
Embodiment 2: first get each component by Rhizoma Belamcandae 14 parts, Rhizoma Polygoni Cuspidati 15 parts, Lignum Sappan 9 parts, Radix Scutellariae 18 parts, Flos Farfarae 9 parts, Bulbus Allii Macrostemonis 30 parts, Folium Isatidis 19 parts, Myrrha 18 parts, Radix Scutellariae 13 parts, Semen Lepidii (Semen Descurainiae) 8 parts, bamboo charcoal 10 parts, 12 parts, Fructus Gleditsia, Herba Taraxaci 15 parts, Fructus Cnidii 9 parts; Each component mixed, after spraying vinegar on the mixture, dry stir-fry, is exposed to the sun the medicine of fried dry after 24h, is ground into fine powder, crosses 200 mesh sieves, adds water, stir, obtain the medicament decoction B of this treatment chronic obstructive pulmonary disease with the ratio by weight 1:1 in the mixed-powder sieved.
Embodiment 3: first get each component by Rhizoma Belamcandae 16 parts, Rhizoma Polygoni Cuspidati 13 parts, Lignum Sappan 10 parts, Radix Scutellariae 17 parts, Flos Farfarae 10 parts, Bulbus Allii Macrostemonis 27 parts, Folium Isatidis 20 parts, Myrrha 15 parts, Radix Scutellariae 14 parts, Semen Lepidii (Semen Descurainiae) 6 parts, bamboo charcoal 12 parts, 9 parts, Fructus Gleditsia, Herba Taraxaci 18 parts, Fructus Cnidii 6 parts; Each component mixed, after spraying vinegar on the mixture, dry stir-fry, is exposed to the sun the medicine of fried dry after 24h, is ground into fine powder, crosses 200 mesh sieves, adds water, stir, obtain the medicament decoction C of this treatment chronic obstructive pulmonary disease with the ratio by weight 1:1 in the mixed-powder sieved.
Embodiment 4: first get each component by Rhizoma Belamcandae 17 parts, Rhizoma Polygoni Cuspidati 12 parts, Lignum Sappan 10 parts, Radix Scutellariae 16 parts, Flos Farfarae 11 parts, Bulbus Allii Macrostemonis 26 parts, Folium Isatidis 21 parts, Myrrha 14 parts, Radix Scutellariae 15 parts, Semen Lepidii (Semen Descurainiae) 5 parts, bamboo charcoal 13 parts, 8 parts, Fructus Gleditsia, Herba Taraxaci 19 parts, Fructus Cnidii 5 parts; Each component mixed, after spraying vinegar on the mixture, dry stir-fry, is exposed to the sun the medicine of fried dry after 24h, is ground into fine powder, crosses 200 mesh sieves, adds water, stir, obtain the medicament decoction D of this treatment chronic obstructive pulmonary disease with the ratio by weight 1:1 in the mixed-powder sieved.
Embodiment 5: first get each component by Rhizoma Belamcandae 15 parts, Rhizoma Polygoni Cuspidati 14 parts, Lignum Sappan 9 parts, Radix Scutellariae 18 parts, Flos Farfarae 9 parts, Bulbus Allii Macrostemonis 28 parts, Folium Isatidis 19 parts, Myrrha 16 parts, Radix Scutellariae 13 parts, Semen Lepidii (Semen Descurainiae) 7 parts, bamboo charcoal 11 parts, 10 parts, Fructus Gleditsia, Herba Taraxaci 17 parts, Fructus Cnidii 7 parts; Each component mixed, after spraying vinegar on the mixture, dry stir-fry, is exposed to the sun the medicine of fried dry after 24h, is ground into fine powder, crosses 200 mesh sieves, adds water, stir, obtain the medicament decoction E of this treatment chronic obstructive pulmonary disease with the ratio by weight 1:1 in the mixed-powder sieved.
In above-mentioned fact Example, the medicament decoction C effect of the treatment chronic obstructive pulmonary disease that embodiment 3 is obtained is the most outstanding, is most preferred embodiment.
Clinical data
To the clinical practice of the patient of 100 example treatment tinea corporis, details are as follows for situation,
(1) analysis of cases: 1. sex: according to entering group standard, treats tinea corporis patient 100 example altogether, wherein male 60 example, women 40 example; 2. the course of disease: 6 months ~ 1 year be 15 examples 2 years ~ 3 years is 50 examples, within more than 3 years, is 35 examples; 3. age group: 20 ~ 30 years old 35 example, 31 ~ 40 years old 5 example, 41 ~ 50 years old 20 example, 51 ~ 60 years old 30 example, more than 60 years old 10 example.
(2) administrated method: oral, every day 2 ~ 3 times, each 5 ~ 6g.
(3) efficacy evaluation: 1. fully recover: transference cure, thoroughly fully recover; 2. remarkable: to cure and do not have recurrence in latter more than 1 year; 3. effective: the complications shape of various different tinea corporis patient significantly reduces; 4. invalid: before and after treatment, change is little, or once takes a turn for the better, after return to again symptom before treatment.
(4) result: (recovery from illness case+significantly case+effectively case)/100 examples=total effective rate, total effective rate reaches 95%.
Above-mentioned embodiment is intended to illustrate that the present invention can be professional and technical personnel in the field and realizes or use; modifying to above-mentioned embodiment will be apparent for those skilled in the art; therefore the present invention includes but be not limited to above-mentioned embodiment; any these claims or description of meeting describes; meet and principle disclosed herein and novelty, the method for inventive features, technique, product, all fall within protection scope of the present invention.
Claims (8)
1. treat the medicament of chronic obstructive pulmonary disease for one kind, it is characterized in that: this medicament is formulated according to shown weight ratio scope by following component, Rhizoma Belamcandae 14 ~ 19 parts, Rhizoma Polygoni Cuspidati 11 ~ 15 parts, Lignum Sappan 9 ~ 10 parts, Radix Scutellariae 15 ~ 18 parts, Flos Farfarae 9 ~ 13 parts, Bulbus Allii Macrostemonis 25 ~ 30 parts, Folium Isatidis 19 ~ 23 parts, Myrrha 12 ~ 18 parts, Radix Scutellariae 13 ~ 17 parts, Semen Lepidii (Semen Descurainiae) 3 ~ 8 parts, bamboo charcoal 10 ~ 13 parts, 8 ~ 12 parts, Fructus Gleditsia, Herba Taraxaci 15 ~ 20 parts, Fructus Cnidii 3 ~ 9 parts.
2. the medicament for the treatment of chronic obstructive pulmonary disease according to claim 1, it is characterized in that: described medicament is formulated according to shown weight ratio scope by following component, Rhizoma Belamcandae 15 ~ 17 parts, Rhizoma Polygoni Cuspidati 12 ~ 14 parts, Lignum Sappan 9 ~ 10 parts, Radix Scutellariae 16 ~ 18 parts, Flos Farfarae 9 ~ 11 parts, Bulbus Allii Macrostemonis 26 ~ 28 parts, Folium Isatidis 19 ~ 21 parts, Myrrha 14 ~ 16 parts, Radix Scutellariae 13 ~ 15 parts, Semen Lepidii (Semen Descurainiae) 5 ~ 7 parts, bamboo charcoal 11 ~ 13 parts, 8 ~ 10 parts, Fructus Gleditsia, Herba Taraxaci 17 ~ 19 parts, Fructus Cnidii 5 ~ 7 parts.
3. the medicament for the treatment of chronic obstructive pulmonary disease according to claim 1, it is characterized in that: described medicament is formulated according to shown weight ratio by following component, Rhizoma Belamcandae 19 parts, Rhizoma Polygoni Cuspidati 11 parts, Lignum Sappan 10 parts, Radix Scutellariae 15 parts, Flos Farfarae 13 parts, Bulbus Allii Macrostemonis 25 parts, Folium Isatidis 23 parts, Myrrha 12 parts, Radix Scutellariae 17 parts, Semen Lepidii (Semen Descurainiae) 3 parts, bamboo charcoal 13 parts, 8 parts, Fructus Gleditsia, Herba Taraxaci 20 parts, Fructus Cnidii 3 parts.
4. the medicament for the treatment of chronic obstructive pulmonary disease according to claim 1, it is characterized in that: described medicament is formulated according to shown weight ratio by following component, Rhizoma Belamcandae 14 parts, Rhizoma Polygoni Cuspidati 15 parts, Lignum Sappan 9 parts, Radix Scutellariae 18 parts, Flos Farfarae 9 parts, Bulbus Allii Macrostemonis 30 parts, Folium Isatidis 19 parts, Myrrha 18 parts, Radix Scutellariae 13 parts, Semen Lepidii (Semen Descurainiae) 8 parts, bamboo charcoal 10 parts, 12 parts, Fructus Gleditsia, Herba Taraxaci 15 parts, Fructus Cnidii 9 parts.
5. the medicament for the treatment of chronic obstructive pulmonary disease according to claim 2, it is characterized in that: described medicament is formulated according to shown weight ratio by following component, described medicine is formulated according to shown weight ratio scope by following component, Rhizoma Belamcandae 16 parts, Rhizoma Polygoni Cuspidati 13 parts, Lignum Sappan 10 parts, Radix Scutellariae 17 parts, Flos Farfarae 10 parts, Bulbus Allii Macrostemonis 27 parts, Folium Isatidis 20 parts, Myrrha 15 parts, Radix Scutellariae 14 parts, Semen Lepidii (Semen Descurainiae) 6 parts, bamboo charcoal 12 parts, 9 parts, Fructus Gleditsia, Herba Taraxaci 18 parts, Fructus Cnidii 6 parts.
6. the medicament for the treatment of chronic obstructive pulmonary disease according to claim 2, it is characterized in that: described medicament is formulated according to shown weight ratio by following component, Rhizoma Belamcandae 17 parts, Rhizoma Polygoni Cuspidati 12 parts, Lignum Sappan 10 parts, Radix Scutellariae 16 parts, Flos Farfarae 11 parts, Bulbus Allii Macrostemonis 26 parts, Folium Isatidis 21 parts, Myrrha 14 parts, Radix Scutellariae 15 parts, Semen Lepidii (Semen Descurainiae) 5 parts, bamboo charcoal 13 parts, 8 parts, Fructus Gleditsia, Herba Taraxaci 19 parts, Fructus Cnidii 5 parts.
7. the medicament for the treatment of chronic obstructive pulmonary disease according to claim 2, it is characterized in that: described medicament is formulated according to shown weight ratio by following component, Rhizoma Belamcandae 15 parts, Rhizoma Polygoni Cuspidati 14 parts, Lignum Sappan 9 parts, Radix Scutellariae 18 parts, Flos Farfarae 9 parts, Bulbus Allii Macrostemonis 28 parts, Folium Isatidis 19 parts, Myrrha 16 parts, Radix Scutellariae 13 parts, Semen Lepidii (Semen Descurainiae) 7 parts, bamboo charcoal 11 parts, 10 parts, Fructus Gleditsia, Herba Taraxaci 17 parts, Fructus Cnidii 7 parts.
8. according to the medicament of the arbitrary described treatment chronic obstructive pulmonary disease of claim 1 to 7, it is characterized in that: described medicament is decoction, its preparation method is, first gets each component according to the arbitrary described weight portion of claim 1 to 7, each component is mixed, after spraying vinegar on the mixture, dry stir-fry, is exposed to the sun the medicine of fried dry after 24h, is ground into fine powder, cross 200 mesh sieves, add water in the mixed-powder sieved with the ratio by weight 1:1, stir, obtain the medicament decoction of this treatment chronic obstructive pulmonary disease.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410458173.8A CN104288544A (en) | 2014-09-09 | 2014-09-09 | Medicament for treating chronic obstructive pulmonary disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410458173.8A CN104288544A (en) | 2014-09-09 | 2014-09-09 | Medicament for treating chronic obstructive pulmonary disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104288544A true CN104288544A (en) | 2015-01-21 |
Family
ID=52308655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410458173.8A Pending CN104288544A (en) | 2014-09-09 | 2014-09-09 | Medicament for treating chronic obstructive pulmonary disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104288544A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101953980A (en) * | 2010-10-14 | 2011-01-26 | 江苏省中医院 | Allium macrostemon and pepperweed seed mixture for treating chronic obstructive pulmonary disease (COPD) by adopting phlegm removing and turbidity resolving method |
| CN103550734A (en) * | 2013-10-21 | 2014-02-05 | 丛月英 | Traditional Chinese medicine decoction for treating chronic bronchitis |
| CN103623263A (en) * | 2013-11-27 | 2014-03-12 | 青岛市市立医院 | Compound traditional Chinese medicine for treating tinea corporis |
| CN103933360A (en) * | 2014-05-05 | 2014-07-23 | 于晓峰 | Traditional Chinese medicinal composition for treating lung fibrosis |
-
2014
- 2014-09-09 CN CN201410458173.8A patent/CN104288544A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101953980A (en) * | 2010-10-14 | 2011-01-26 | 江苏省中医院 | Allium macrostemon and pepperweed seed mixture for treating chronic obstructive pulmonary disease (COPD) by adopting phlegm removing and turbidity resolving method |
| CN103550734A (en) * | 2013-10-21 | 2014-02-05 | 丛月英 | Traditional Chinese medicine decoction for treating chronic bronchitis |
| CN103623263A (en) * | 2013-11-27 | 2014-03-12 | 青岛市市立医院 | Compound traditional Chinese medicine for treating tinea corporis |
| CN103933360A (en) * | 2014-05-05 | 2014-07-23 | 于晓峰 | Traditional Chinese medicinal composition for treating lung fibrosis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103110844B (en) | Traditional Chinese medicine for treating acute tonsillitis | |
| CN103169904B (en) | Traditional Chinese medicine composition for treating lung cancer | |
| CN103816361B (en) | Chinese medicine of prophylactic treatment bird flu and preparation method thereof | |
| CN103585401A (en) | Traditional Chinese medicine composition for treating bird flu and preparation method therefor. | |
| CN102727770B (en) | Pure traditional Chinese medicine composition used for treating swine influenza, and preparation method thereof | |
| CN104147574A (en) | Heat-clearing and exterior-releasing traditional Chinese medicine composition for treating cold and fever and preparation method thereof | |
| CN104857477A (en) | Traditional Chinese medicine for treating bronchial asthma | |
| CN105497723A (en) | Traditional Chinese medicine preparation for treating bacterial pneumonia and preparation method thereof | |
| CN104758606A (en) | Traditional Chinese medicine composition for treating qi-deficiency and sputum-stasis type hepatic hemangioma | |
| CN104288544A (en) | Medicament for treating chronic obstructive pulmonary disease | |
| CN103100013B (en) | Traditional Chinese medicine decoction for treating bronchiectasis | |
| CN103110910B (en) | Agent for treating acute upper respiratory infection | |
| CN110496199B (en) | Medicine for treating psoriasis and preparation method thereof | |
| CN105797007A (en) | Decoction medicine for treatment of pneumonia and preparation method thereof | |
| CN105267687A (en) | Traditional Chinese medicine preparation for treating acute tonsillitis and preparation method thereof | |
| CN103768571B (en) | The Chinese medicine composition for the treatment of children chronic bronchitis and preparation method | |
| CN104398778A (en) | Traditional Chinese medicine for treating pneumonia | |
| CN108524651A (en) | A kind of Chinese medicine preparation for treating tracheitis | |
| CN103223157B (en) | Traditional Chinese medicine composition used for treating cold | |
| CN103877169B (en) | A kind of compositions for the treatment of cough | |
| CN104435695A (en) | Traditional Chinese medicine composition for treating bronchiectasia at stable stage and preparation of traditional Chinese medicine composition | |
| CN104398793A (en) | Traditional Chinese medicine composition for treating radiation pneumonitis and preparation method of traditional Chinese medicine composition | |
| CN106075028A (en) | A kind of Chinese medicinal capsule curing lung tumor | |
| CN109692247A (en) | A kind of Antiphlogistic Powder of Schizonepetae and Ledebouriellae adds taste secret recipe | |
| CN102309664A (en) | Preparation for treating AIDS and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150121 |
|
| RJ01 | Rejection of invention patent application after publication |